Physician profile
James W Rust
NPI 1134141617
$2,961.30
in general payments reported to CMS, 2019-2025
25 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $217 · 2021: $155 · 2022: $113 · 2023: $756 · 2024: $904 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $510.45 | 2023-2025 | Augment Injectable, Infinity Adaptis, Infinity |
| Horizon Therapeutics Plc | $488.05 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $473.38 | 2019-2025 | Grafix Pl, Stravix Pl, Renasys Go V2 Home |
| Trilliant Surgical LLC. | $206.62 | 2019 | |
| Sanara Medtech INC. | $156.87 | 2023 | Celleraterx |
| Linvatec Corporation | $154.78 | 2024 | Biobrace 23mm |
| Orthofix Medical, INC. | $149.98 | 2019-2023 | Spinal-Stim, Physio-Stim |
| Shockwave Medical, INC | $140.40 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Paragon 28, INC. | $132.64 | 2023 | Portfolio |
| Zimmer Biomet Holdings, INC. | $88.32 | 2019-2021 | |
| Abbvie INC. | $71.00 | 2023-2024 | Dalvance |
| Amgen INC. | $56.37 | 2024 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $44.31 | 2024 | Nuzyra |
| Zimvie INC. | $40.35 | 2022-2023 | |
| Lifenet Health | $40.08 | 2024 | Theragenesis Wound Matrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $38.98 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $31.34 | 2023 | Puraply |
| Bioventus LLC | $31.15 | 2019-2021 | |
| Next Science LLC | $18.59 | 2023 | Blastx, Surgx, Xperience |
| Sandoz INC. | $18.48 | 2019 | |
| Acera Surgical, INC. | $16.93 | 2023 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $16.60 | 2020 | |
| Kerecis Limited | $13.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Merck Sharp & Dohme LLC | $11.11 | 2019 | |
| Baxter Healthcare | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.